Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines

As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile an...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 14; no. 1; p. 8047
Main Authors Bhatta, Rimsha, Han, Joonsu, Liu, Yusheng, Bo, Yang, Lee, David, Zhou, Jiadiao, Wang, Yueji, Nelson, Erik Russell, Chen, Qian, Zhang, Xiaojia Shelly, Hassaneen, Wael, Wang, Hua
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 05.12.2023
Nature Publishing Group
Nature Portfolio
Subjects
13/31
14/1
14/19
14/34
631/250/251/1567
631/61/350/354
631/67/1059/2325
631/67/1059/4042
639/166/985
Antitumor activity
Cancer
Cancer vaccines
Cancer Vaccines - metabolism
CD8 antigen
Cell activation
Cell Communication
Cell interactions
Cellular communication
Chemical synthesis
Conjugation
Dendritic cells
Extracellular vesicles
Extracellular Vesicles - metabolism
Humanities and Social Sciences
Humans
Lymphocytes
Lymphocytes T
Lymphoma
Melanoma
Metabolism
multidisciplinary
Science
Science (multidisciplinary)
Skin Neoplasms - metabolism
Survival
Tags
Therapeutic applications
Toll-like receptors
Tumors
Vaccines
Vesicles
Online AccessGet full text

Cover

Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8 + T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines. Extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. Here, the authors report a universal metabolic tagging technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV-based cancer vaccines.
AbstractList As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8+ T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines.Extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. Here, the authors report a universal metabolic tagging technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV-based cancer vaccines.
As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8+ T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines.
As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8 + T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines. Extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. Here, the authors report a universal metabolic tagging technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV-based cancer vaccines.
As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8 T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines.
Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8 + T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines.
Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8+ T cell response. These lead to 80% tumor-free survival against E.G7 lymphoma and 33% tumor-free survival against B16F10 melanoma. Our study yields a universal technology to generate chemically tagged EVs from parent cells, modulate EV-cell interactions, and develop potent EV vaccines.
ArticleNumber 8047
Author Han, Joonsu
Bo, Yang
Bhatta, Rimsha
Zhou, Jiadiao
Nelson, Erik Russell
Wang, Yueji
Zhang, Xiaojia Shelly
Lee, David
Liu, Yusheng
Wang, Hua
Hassaneen, Wael
Chen, Qian
Author_xml – sequence: 1
  givenname: Rimsha
  surname: Bhatta
  fullname: Bhatta, Rimsha
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 2
  givenname: Joonsu
  orcidid: 0000-0002-7794-0661
  surname: Han
  fullname: Han, Joonsu
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 3
  givenname: Yusheng
  surname: Liu
  fullname: Liu, Yusheng
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 4
  givenname: Yang
  surname: Bo
  fullname: Bo, Yang
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 5
  givenname: David
  surname: Lee
  fullname: Lee, David
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 6
  givenname: Jiadiao
  surname: Zhou
  fullname: Zhou, Jiadiao
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign
– sequence: 7
  givenname: Yueji
  surname: Wang
  fullname: Wang, Yueji
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Department of Mechanical Science and Engineering, University of Illinois Urbana-Champaign
– sequence: 8
  givenname: Erik Russell
  orcidid: 0000-0002-8887-1905
  surname: Nelson
  fullname: Nelson, Erik Russell
  organization: Cancer Center at Illinois (CCIL), Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Department of Molecular and Integrative Physiology, University of Illinois at Urbana
– sequence: 9
  givenname: Qian
  orcidid: 0000-0002-1968-441X
  surname: Chen
  fullname: Chen, Qian
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Materials Research Laboratory, University of Illinois at Urbana-Champaign
– sequence: 10
  givenname: Xiaojia Shelly
  orcidid: 0000-0003-4878-8637
  surname: Zhang
  fullname: Zhang, Xiaojia Shelly
  organization: Department of Mechanical Science and Engineering, University of Illinois Urbana-Champaign, Department of Civil and Environmental Engineering, University of Illinois at Urbana-Champaign, National Center for Supercomputing Applications
– sequence: 11
  givenname: Wael
  surname: Hassaneen
  fullname: Hassaneen, Wael
  organization: Carle College of Medicine, University of Illinois at Urbana-Champaign, Carle Foundation Hospital
– sequence: 12
  givenname: Hua
  orcidid: 0000-0002-1157-8786
  surname: Wang
  fullname: Wang, Hua
  email: huawang3@illinois.edu
  organization: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Cancer Center at Illinois (CCIL), Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Materials Research Laboratory, University of Illinois at Urbana-Champaign, Carle College of Medicine, University of Illinois at Urbana-Champaign, Department of Bioengineering, University of Illinois at Urbana-Champaign
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38052869$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9v1DAQxS3UipbSL8ABReLSS6gd_z-iCkqlol7gbE2cScgqay92UpVvj3dTCkKovtia-b3nGb1X5CjEgIS8YfQ9o9xcZsGE0jVteC24ZaI2L8hpQwWrmW740V_vE3Ke84aWUzgjxEtywg2VjVH2lOQvOEMbp9FXMwzDGIYq9hU-zAk8TtMyQaruMY9-wlxB6KoO73GKuy2G-UCG7xA8dv-XVC3k0vN7pBTB-zFgfk2Oe5gynj_eZ-Tbp49frz7Xt3fXN1cfbmsvjJxr0K2wSsgWpZcKjFLMq7btNdWouRTKUy11rwz0lluqbW-Ao-2s4LRlvONn5Gb17SJs3C6NW0g_XYTRHQoxDQ7SvJ_TMW9pV2y8Yii8ANNLqTvrpS_u0tridbF67VL8sWCe3XbM-3UhYFyya4w1VmqmdUHf_YNu4pJC2fRAMSWZoIVqVsqnmHPC_mlARt0-Ybcm7ErC7pCwM0X09tF6abfYPUl-51kAvgK5tMKA6c_fz9j-Arm2s0A
CitedBy_id crossref_primary_10_1186_s12989_024_00568_8
crossref_primary_10_1038_s41467_024_46436_z
crossref_primary_10_1016_j_ijpharm_2024_124410
crossref_primary_10_1016_j_nantod_2024_102377
crossref_primary_10_1016_j_apsb_2024_06_010
crossref_primary_10_3390_ijms25115915
crossref_primary_10_1021_jacsau_4c00338
crossref_primary_10_1021_acs_nanolett_4c01711
Cites_doi 10.1002/biot.201900163
10.1073/pnas.0911116107
10.1002/wnan.1824
10.1586/14760584.2015.966085
10.1126/science.1155106
10.1073/pnas.0707090104
10.1038/s41467-018-05077-9
10.1016/bs.mie.2019.05.020
10.1182/blood-2004-03-0824
10.1038/s41563-018-0147-9
10.1016/S0021-9258(19)41417-8
10.1016/j.biopha.2022.113690
10.1016/j.biomaterials.2016.09.031
10.1038/nchembio.2297
10.1016/j.biomaterials.2021.120964
10.1016/j.jconrel.2015.06.029
10.1586/erv.10.174
10.1038/s41467-020-19540-z
10.1038/nature02791
10.1126/science.1093620
10.1038/s41577-019-0269-6
10.1126/science.1115253
10.1056/NEJMoa1001294
10.1016/j.biomaterials.2019.119305
10.1186/s12964-022-00959-4
10.1021/bc500291r
10.1038/s41557-020-00587-w
10.1172/JCI81135
10.1016/j.imlet.2021.08.004
10.1002/anie.201509601
10.1038/nprot.2007.422
10.1096/fj.08-122184
10.1080/1061186X.2019.1641508
10.1038/nm1100
10.1038/s41598-017-01731-2
10.1038/mt.2008.1
10.1016/bs.acc.2015.12.005
10.1016/j.jconrel.2020.12.017
10.3390/cancers15102838
10.4049/jimmunol.178.11.6867
10.1016/j.imlet.2018.05.002
10.4049/jimmunol.180.5.3081
10.1073/pnas.75.7.3317
10.1038/s41563-020-0680-1
10.1038/nrd3500
10.1016/S0076-6879(06)15015-6
10.1016/j.canlet.2017.09.022
10.1038/s41467-020-15569-2
10.1016/j.xpro.2022.101664
10.1021/acs.chemrev.5b00109
10.3389/fimmu.2021.711565
10.3791/2259
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PIMPY
PQEST
PQQKQ
PQUKI
RC3
SOI
7X8
DOA
DOI 10.1038/s41467-023-43914-8
DatabaseName SpringerOpen
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Technology Collection
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 8047
ExternalDocumentID oai_doaj_org_article_1c90df93c61e4c4a8f557d9c5c8af599
10_1038_s41467_023_43914_8
38052869
Genre Journal Article
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
– fundername: United States Department of Defense | Defense Advanced Research Projects Agency (DARPA)
  grantid: N660012314013
  funderid: https://doi.org/10.13039/100000185
– fundername: United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (AF Office of Scientific Research)
  grantid: FA9550-23-1-0609
  funderid: https://doi.org/10.13039/100000181
– fundername: U.S. Department of Health & Human Services | National Institutes of Health (NIH)
  grantid: R01CA234025
  funderid: https://doi.org/10.13039/100000002
– fundername: National Science Foundation (NSF)
  grantid: DMR 2143673 CAR
  funderid: https://doi.org/10.13039/100000001
– fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
  grantid: NIH R01CA274738; NIH R21CA270872
  funderid: https://doi.org/10.13039/100000054
– fundername: NIBIB NIH HHS
  grantid: T32 EB019944
– fundername: NCI NIH HHS
  grantid: R01 CA274738
– fundername: NCI NIH HHS
  grantid: R01 CA234025
– fundername: NCI NIH HHS
  grantid: R21 CA270872
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADRAZ
AENEX
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PQEST
PQUKI
RC3
SOI
7X8
ID FETCH-LOGICAL-c485t-a7b49645be5c56a8661c6bbf707e73546c0757f68af939079f8a3e9d9430b13d3
IEDL.DBID M48
ISSN 2041-1723
IngestDate Tue Oct 22 15:15:00 EDT 2024
Fri Oct 25 05:34:14 EDT 2024
Sun Oct 27 03:21:23 EDT 2024
Fri Aug 23 02:42:02 EDT 2024
Sat Nov 02 12:30:04 EDT 2024
Fri Oct 11 20:46:34 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-a7b49645be5c56a8661c6bbf707e73546c0757f68af939079f8a3e9d9430b13d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1968-441X
0000-0002-7794-0661
0000-0002-8887-1905
0000-0003-4878-8637
0000-0002-1157-8786
OpenAccessLink https://doi.org/10.1038/s41467-023-43914-8
PMID 38052869
PQID 2898165140
PQPubID 546298
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_1c90df93c61e4c4a8f557d9c5c8af599
proquest_miscellaneous_2898957177
proquest_journals_2898165140
crossref_primary_10_1038_s41467_023_43914_8
pubmed_primary_38052869
springer_journals_10_1038_s41467_023_43914_8
PublicationCentury 2000
PublicationDate 12-5-2023
PublicationDateYYYYMMDD 2023-12-05
PublicationDate_xml – month: 12
  year: 2023
  text: 12-5-2023
  day: 05
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Carpenter, Lembach, Morrison, Cohen (CR6) 1975; 250
Choe, Kelker, Wilson (CR36) 2005; 309
Prescher, Dube, Bertozzi (CR42) 2004; 430
Laughlin, Bertozzi (CR18) 2007; 2
Imai, Leung, Friesen, Shiu (CR4) 1982; 42
Montecalvo (CR23) 2008; 180
Hosseini (CR13) 2022; 155
Wang (CR41) 2020; 19
Laughlin (CR43) 2006; 415
Dai (CR30) 2008; 16
Irvine, Hanson, Rakhra, Tokatlian (CR39) 2015; 115
Fendly (CR7) 1990; 50
Cheng, Zhang, Tang, Lv, Liu (CR9) 2021; 275
Morales-Kastresana (CR26) 2017; 7
Laughlin, Baskin, Amacher, Bertozzi (CR19) 2008; 320
Wang (CR16) 2017; 13
Wang (CR17) 2016; 55
Wang, Mooney (CR15) 2020; 12
Whiteside (CR1) 2016; 74
Liu (CR35) 2017; 411
Torralba (CR25) 2018; 9
Baskin (CR20) 2007; 104
Bode (CR47) 2011; 10
Si (CR12) 2020; 15
Haigler, Ash, Singer, Cohen (CR5) 1978; 75
Severic (CR10) 2021; 330
Milane, Singh, Mattheolabakis, Suresh, Amiji (CR2) 2015; 219
Morelli (CR24) 2004; 104
Graner (CR28) 2009; 23
Smyth (CR11) 2014; 25
Irvine, Dane (CR40) 2020; 20
Ning (CR33) 2018; 199
CR54
Martins, Bavari, Salazar (CR48) 2015; 14
Terrén, Orrantia, Vitallé, Zenarruzabeitia, Borrego (CR53) 2020; 631
Lesterhuis, Haanen, Punt (CR29) 2011; 10
Kantoff (CR46) 2010; 363
Yildirim (CR50) 2021; 239
Wang (CR38) 2020; 11
Zuo (CR51) 2020; 11
Kalluri (CR3) 2016; 126
Rezaie, Feghhi, Etemadi (CR32) 2022; 20
CR27
Morishita, Takahashi, Matsumoto, Nishikawa, Takakura (CR31) 2016; 111
Sauter (CR52) 2022; 3
Johnson, Vasu, Kumar, Kumar (CR14) 2023; 15
Wang, Mooney (CR44) 2018; 17
Rosenberg, Yang, Restifo (CR45) 2004; 10
Yu (CR34) 2007; 178
Heil (CR37) 2004; 303
Chang (CR21) 2010; 107
Bo, Wang (CR49) 2022; 14
Lin, Lu, Li (CR8) 2020; 28
Wang (CR22) 2019; 218
J Rezaie (43914_CR32) 2022; 20
DJ Irvine (43914_CR39) 2015; 115
ST Laughlin (43914_CR18) 2007; 2
M Morishita (43914_CR31) 2016; 111
S Yu (43914_CR34) 2007; 178
BM Fendly (43914_CR7) 1990; 50
Y Si (43914_CR12) 2020; 15
D Torralba (43914_CR25) 2018; 9
H Wang (43914_CR44) 2018; 17
SA Rosenberg (43914_CR45) 2004; 10
G Carpenter (43914_CR6) 1975; 250
Y Lin (43914_CR8) 2020; 28
L Milane (43914_CR2) 2015; 219
I Terrén (43914_CR53) 2020; 631
R Kalluri (43914_CR3) 2016; 126
H Haigler (43914_CR5) 1978; 75
A Montecalvo (43914_CR23) 2008; 180
T Smyth (43914_CR11) 2014; 25
H Liu (43914_CR35) 2017; 411
PW Kantoff (43914_CR46) 2010; 363
A Morales-Kastresana (43914_CR26) 2017; 7
ST Laughlin (43914_CR19) 2008; 320
JM Baskin (43914_CR20) 2007; 104
S Dai (43914_CR30) 2008; 16
F Heil (43914_CR37) 2004; 303
AE Morelli (43914_CR24) 2004; 104
DJ Irvine (43914_CR40) 2020; 20
L Cheng (43914_CR9) 2021; 275
NF Hosseini (43914_CR13) 2022; 155
H Wang (43914_CR17) 2016; 55
H Wang (43914_CR15) 2020; 12
43914_CR54
PV Chang (43914_CR21) 2010; 107
H Wang (43914_CR16) 2017; 13
Y Ning (43914_CR33) 2018; 199
C Bode (43914_CR47) 2011; 10
KA Martins (43914_CR48) 2015; 14
J Choe (43914_CR36) 2005; 309
MW Graner (43914_CR28) 2009; 23
43914_CR27
TL Whiteside (43914_CR1) 2016; 74
JA Prescher (43914_CR42) 2004; 430
H Wang (43914_CR41) 2020; 19
Y Bo (43914_CR49) 2022; 14
M Severic (43914_CR10) 2021; 330
M Sauter (43914_CR52) 2022; 3
V Johnson (43914_CR14) 2023; 15
ST Laughlin (43914_CR43) 2006; 415
WJ Lesterhuis (43914_CR29) 2011; 10
H Wang (43914_CR22) 2019; 218
H Wang (43914_CR38) 2020; 11
Y Imai (43914_CR4) 1982; 42
B Zuo (43914_CR51) 2020; 11
M Yildirim (43914_CR50) 2021; 239
References_xml – volume: 15
  start-page: 1900163
  year: 2020
  ident: CR12
  article-title: Targeted exosomes for drug delivery: biomanufacturing, surface tagging, and validation
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.201900163
  contributor:
    fullname: Si
– volume: 107
  start-page: 1821
  year: 2010
  end-page: 1826
  ident: CR21
  article-title: Copper-free click chemistry in living animals
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0911116107
  contributor:
    fullname: Chang
– volume: 14
  start-page: e1824
  year: 2022
  ident: CR49
  article-title: Materials-based vaccines for infectious diseases
  publication-title: WIREs Nanomed. Nanobiotechnol.
  doi: 10.1002/wnan.1824
  contributor:
    fullname: Wang
– volume: 14
  start-page: 447
  year: 2015
  end-page: 459
  ident: CR48
  article-title: Vaccine adjuvant uses of poly-IC and derivatives
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2015.966085
  contributor:
    fullname: Salazar
– volume: 320
  start-page: 664
  year: 2008
  end-page: 667
  ident: CR19
  article-title: In vivo imaging of membrane-associated glycans in developing zebrafish
  publication-title: Science
  doi: 10.1126/science.1155106
  contributor:
    fullname: Bertozzi
– volume: 104
  start-page: 16793
  year: 2007
  end-page: 16797
  ident: CR20
  article-title: Copper-free click chemistry for dynamic in vivo imaging
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0707090104
  contributor:
    fullname: Baskin
– volume: 9
  year: 2018
  ident: CR25
  article-title: Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-05077-9
  contributor:
    fullname: Torralba
– volume: 631
  start-page: 239
  year: 2020
  end-page: 255
  ident: CR53
  article-title: CFSE dilution to study human T and NK cell proliferation in vitro
  publication-title: Methods Enzymol.
  doi: 10.1016/bs.mie.2019.05.020
  contributor:
    fullname: Borrego
– volume: 104
  start-page: 3257
  year: 2004
  end-page: 3266
  ident: CR24
  article-title: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0824
  contributor:
    fullname: Morelli
– ident: CR54
– volume: 17
  start-page: 761
  year: 2018
  end-page: 772
  ident: CR44
  article-title: Biomaterial-assisted targeted modulation of immune cells in cancer treatment
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0147-9
  contributor:
    fullname: Mooney
– volume: 250
  start-page: 4297
  year: 1975
  end-page: 4304
  ident: CR6
  article-title: Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)41417-8
  contributor:
    fullname: Cohen
– volume: 155
  start-page: 113690
  year: 2022
  ident: CR13
  article-title: AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer
  publication-title: Biomed. Pharmther.
  doi: 10.1016/j.biopha.2022.113690
  contributor:
    fullname: Hosseini
– volume: 111
  start-page: 55
  year: 2016
  end-page: 65
  ident: CR31
  article-title: Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.09.031
  contributor:
    fullname: Takakura
– volume: 13
  start-page: 415
  year: 2017
  ident: CR16
  article-title: Selective in vivo metabolic cell-labeling-mediated cancer targeting
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2297
  contributor:
    fullname: Wang
– volume: 275
  start-page: 120964
  year: 2021
  ident: CR9
  article-title: Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.120964
  contributor:
    fullname: Liu
– volume: 219
  start-page: 278
  year: 2015
  end-page: 294
  ident: CR2
  article-title: Exosome mediated communication within the tumor microenvironment
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2015.06.029
  contributor:
    fullname: Amiji
– volume: 10
  start-page: 499
  year: 2011
  end-page: 511
  ident: CR47
  article-title: as a vaccine adjuvant
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/erv.10.174
  contributor:
    fullname: Bode
– volume: 11
  year: 2020
  ident: CR38
  article-title: Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19540-z
  contributor:
    fullname: Wang
– volume: 430
  start-page: 873
  year: 2004
  end-page: 877
  ident: CR42
  article-title: Chemical remodelling of cell surfaces in living animals
  publication-title: Nature
  doi: 10.1038/nature02791
  contributor:
    fullname: Bertozzi
– volume: 303
  start-page: 1526
  year: 2004
  end-page: 1529
  ident: CR37
  article-title: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
  publication-title: Science
  doi: 10.1126/science.1093620
  contributor:
    fullname: Heil
– volume: 20
  start-page: 321
  year: 2020
  end-page: 334
  ident: CR40
  article-title: Enhancing cancer immunotherapy with nanomedicine
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-019-0269-6
  contributor:
    fullname: Dane
– volume: 309
  start-page: 581
  year: 2005
  end-page: 585
  ident: CR36
  article-title: Crystal structure of human toll-like receptor 3 (TLR3) ectodomain
  publication-title: Science
  doi: 10.1126/science.1115253
  contributor:
    fullname: Wilson
– volume: 363
  start-page: 411
  year: 2010
  end-page: 422
  ident: CR46
  article-title: Sipuleucel-T immunotherapy for castration-resistant prostate cancer
  publication-title: N Engl. J. Med.
  doi: 10.1056/NEJMoa1001294
  contributor:
    fullname: Kantoff
– volume: 218
  start-page: 119305
  year: 2019
  ident: CR22
  article-title: In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.119305
  contributor:
    fullname: Wang
– volume: 20
  start-page: 1
  year: 2022
  end-page: 13
  ident: CR32
  article-title: A review on exosomes application in clinical trials: perspective, questions, and challenges
  publication-title: Cell Commun. Signal.
  doi: 10.1186/s12964-022-00959-4
  contributor:
    fullname: Etemadi
– volume: 25
  start-page: 1777
  year: 2014
  end-page: 1784
  ident: CR11
  article-title: Surface functionalization of exosomes using click chemistry
  publication-title: Bioconj. Chem.
  doi: 10.1021/bc500291r
  contributor:
    fullname: Smyth
– volume: 12
  start-page: 1102
  year: 2020
  end-page: 1114
  ident: CR15
  article-title: Metabolic glycan labelling for cancer-targeted therapy
  publication-title: Nat. Chem.
  doi: 10.1038/s41557-020-00587-w
  contributor:
    fullname: Mooney
– volume: 126
  start-page: 1208
  year: 2016
  end-page: 1215
  ident: CR3
  article-title: The biology and function of exosomes in cancer
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI81135
  contributor:
    fullname: Kalluri
– volume: 239
  start-page: 32
  year: 2021
  end-page: 41
  ident: CR50
  article-title: TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2021.08.004
  contributor:
    fullname: Yildirim
– volume: 42
  start-page: 4394
  year: 1982
  end-page: 4398
  ident: CR4
  article-title: Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture
  publication-title: Cancer Res.
  contributor:
    fullname: Shiu
– volume: 55
  start-page: 5452
  year: 2016
  end-page: 5456
  ident: CR17
  article-title: Targeted ultrasound-assisted cancer-selective chemical labeling and subsequent cancer imaging using click chemistry
  publication-title: Angew Chem. Int. Ed.
  doi: 10.1002/anie.201509601
  contributor:
    fullname: Wang
– volume: 2
  start-page: 2930
  year: 2007
  ident: CR18
  article-title: Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2007.422
  contributor:
    fullname: Bertozzi
– volume: 23
  start-page: 1541
  year: 2009
  end-page: 1557
  ident: CR28
  article-title: Proteomic and immunologic analyses of brain tumor exosomes
  publication-title: FASEB J.
  doi: 10.1096/fj.08-122184
  contributor:
    fullname: Graner
– volume: 28
  start-page: 129
  year: 2020
  end-page: 141
  ident: CR8
  article-title: Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents
  publication-title: J. Drug Target.
  doi: 10.1080/1061186X.2019.1641508
  contributor:
    fullname: Li
– volume: 10
  start-page: 909
  year: 2004
  end-page: 915
  ident: CR45
  article-title: Cancer immunotherapy: moving beyond current vaccines
  publication-title: Nat. Med.
  doi: 10.1038/nm1100
  contributor:
    fullname: Restifo
– volume: 7
  year: 2017
  ident: CR26
  article-title: Labeling extracellular vesicles for nanoscale flow cytometry
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-01731-2
  contributor:
    fullname: Morales-Kastresana
– volume: 16
  start-page: 782
  year: 2008
  end-page: 790
  ident: CR30
  article-title: Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2008.1
  contributor:
    fullname: Dai
– ident: CR27
– volume: 74
  start-page: 103
  year: 2016
  end-page: 141
  ident: CR1
  article-title: Tumor-derived exosomes and their role in cancer progression
  publication-title: Adv. Clin. Chem.
  doi: 10.1016/bs.acc.2015.12.005
  contributor:
    fullname: Whiteside
– volume: 330
  start-page: 101
  year: 2021
  end-page: 110
  ident: CR10
  article-title: Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2020.12.017
  contributor:
    fullname: Severic
– volume: 50
  start-page: 1550
  year: 1990
  end-page: 1558
  ident: CR7
  article-title: Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product
  publication-title: Cancer Res.
  contributor:
    fullname: Fendly
– volume: 15
  start-page: 2838
  year: 2023
  ident: CR14
  article-title: Surface-engineered extracellular vesicles in cancer immunotherapy
  publication-title: Cancers
  doi: 10.3390/cancers15102838
  contributor:
    fullname: Kumar
– volume: 178
  start-page: 6867
  year: 2007
  end-page: 6875
  ident: CR34
  article-title: Tumor exosomes inhibit differentiation of bone marrow dendritic cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.11.6867
  contributor:
    fullname: Yu
– volume: 199
  start-page: 36
  year: 2018
  end-page: 43
  ident: CR33
  article-title: Tumor exosomes block dendritic cells maturation to decrease the T cell immune response
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2018.05.002
  contributor:
    fullname: Ning
– volume: 180
  start-page: 3081
  year: 2008
  end-page: 3090
  ident: CR23
  article-title: Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.5.3081
  contributor:
    fullname: Montecalvo
– volume: 75
  start-page: 3317
  year: 1978
  end-page: 3321
  ident: CR5
  article-title: Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.75.7.3317
  contributor:
    fullname: Cohen
– volume: 19
  start-page: 1244
  year: 2020
  end-page: 1252
  ident: CR41
  article-title: Metabolic labeling and targeted modulation of dendritic cells
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-020-0680-1
  contributor:
    fullname: Wang
– volume: 10
  start-page: 591
  year: 2011
  end-page: 600
  ident: CR29
  article-title: Cancer immunotherapy–revisited
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd3500
  contributor:
    fullname: Punt
– volume: 415
  start-page: 230
  year: 2006
  end-page: 250
  ident: CR43
  article-title: Metabolic labeling of glycans with azido sugars for visualization and glycoproteomics
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(06)15015-6
  contributor:
    fullname: Laughlin
– volume: 411
  start-page: 182
  year: 2017
  end-page: 190
  ident: CR35
  article-title: Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.09.022
  contributor:
    fullname: Liu
– volume: 11
  start-page: 1
  year: 2020
  end-page: 16
  ident: CR51
  article-title: Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-15569-2
  contributor:
    fullname: Zuo
– volume: 3
  start-page: 101664
  year: 2022
  ident: CR52
  article-title: Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)
  publication-title: STAR Protoc.
  doi: 10.1016/j.xpro.2022.101664
  contributor:
    fullname: Sauter
– volume: 115
  start-page: 11109
  year: 2015
  end-page: 11146
  ident: CR39
  article-title: Synthetic nanoparticles for vaccines and immunotherapy
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00109
  contributor:
    fullname: Tokatlian
– volume: 9
  year: 2018
  ident: 43914_CR25
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-05077-9
  contributor:
    fullname: D Torralba
– volume: 10
  start-page: 591
  year: 2011
  ident: 43914_CR29
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd3500
  contributor:
    fullname: WJ Lesterhuis
– volume: 10
  start-page: 909
  year: 2004
  ident: 43914_CR45
  publication-title: Nat. Med.
  doi: 10.1038/nm1100
  contributor:
    fullname: SA Rosenberg
– volume: 15
  start-page: 1900163
  year: 2020
  ident: 43914_CR12
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.201900163
  contributor:
    fullname: Y Si
– volume: 2
  start-page: 2930
  year: 2007
  ident: 43914_CR18
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2007.422
  contributor:
    fullname: ST Laughlin
– volume: 631
  start-page: 239
  year: 2020
  ident: 43914_CR53
  publication-title: Methods Enzymol.
  doi: 10.1016/bs.mie.2019.05.020
  contributor:
    fullname: I Terrén
– volume: 12
  start-page: 1102
  year: 2020
  ident: 43914_CR15
  publication-title: Nat. Chem.
  doi: 10.1038/s41557-020-00587-w
  contributor:
    fullname: H Wang
– volume: 104
  start-page: 3257
  year: 2004
  ident: 43914_CR24
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0824
  contributor:
    fullname: AE Morelli
– volume: 107
  start-page: 1821
  year: 2010
  ident: 43914_CR21
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0911116107
  contributor:
    fullname: PV Chang
– ident: 43914_CR27
  doi: 10.3389/fimmu.2021.711565
– volume: 42
  start-page: 4394
  year: 1982
  ident: 43914_CR4
  publication-title: Cancer Res.
  contributor:
    fullname: Y Imai
– volume: 430
  start-page: 873
  year: 2004
  ident: 43914_CR42
  publication-title: Nature
  doi: 10.1038/nature02791
  contributor:
    fullname: JA Prescher
– volume: 199
  start-page: 36
  year: 2018
  ident: 43914_CR33
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2018.05.002
  contributor:
    fullname: Y Ning
– volume: 250
  start-page: 4297
  year: 1975
  ident: 43914_CR6
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)41417-8
  contributor:
    fullname: G Carpenter
– volume: 3
  start-page: 101664
  year: 2022
  ident: 43914_CR52
  publication-title: STAR Protoc.
  doi: 10.1016/j.xpro.2022.101664
  contributor:
    fullname: M Sauter
– volume: 17
  start-page: 761
  year: 2018
  ident: 43914_CR44
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0147-9
  contributor:
    fullname: H Wang
– volume: 25
  start-page: 1777
  year: 2014
  ident: 43914_CR11
  publication-title: Bioconj. Chem.
  doi: 10.1021/bc500291r
  contributor:
    fullname: T Smyth
– volume: 239
  start-page: 32
  year: 2021
  ident: 43914_CR50
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2021.08.004
  contributor:
    fullname: M Yildirim
– volume: 126
  start-page: 1208
  year: 2016
  ident: 43914_CR3
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI81135
  contributor:
    fullname: R Kalluri
– volume: 15
  start-page: 2838
  year: 2023
  ident: 43914_CR14
  publication-title: Cancers
  doi: 10.3390/cancers15102838
  contributor:
    fullname: V Johnson
– volume: 180
  start-page: 3081
  year: 2008
  ident: 43914_CR23
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.5.3081
  contributor:
    fullname: A Montecalvo
– volume: 320
  start-page: 664
  year: 2008
  ident: 43914_CR19
  publication-title: Science
  doi: 10.1126/science.1155106
  contributor:
    fullname: ST Laughlin
– volume: 218
  start-page: 119305
  year: 2019
  ident: 43914_CR22
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.119305
  contributor:
    fullname: H Wang
– volume: 11
  year: 2020
  ident: 43914_CR38
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19540-z
  contributor:
    fullname: H Wang
– volume: 219
  start-page: 278
  year: 2015
  ident: 43914_CR2
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2015.06.029
  contributor:
    fullname: L Milane
– volume: 104
  start-page: 16793
  year: 2007
  ident: 43914_CR20
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0707090104
  contributor:
    fullname: JM Baskin
– volume: 309
  start-page: 581
  year: 2005
  ident: 43914_CR36
  publication-title: Science
  doi: 10.1126/science.1115253
  contributor:
    fullname: J Choe
– volume: 74
  start-page: 103
  year: 2016
  ident: 43914_CR1
  publication-title: Adv. Clin. Chem.
  doi: 10.1016/bs.acc.2015.12.005
  contributor:
    fullname: TL Whiteside
– volume: 111
  start-page: 55
  year: 2016
  ident: 43914_CR31
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.09.031
  contributor:
    fullname: M Morishita
– volume: 50
  start-page: 1550
  year: 1990
  ident: 43914_CR7
  publication-title: Cancer Res.
  contributor:
    fullname: BM Fendly
– volume: 115
  start-page: 11109
  year: 2015
  ident: 43914_CR39
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00109
  contributor:
    fullname: DJ Irvine
– volume: 178
  start-page: 6867
  year: 2007
  ident: 43914_CR34
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.11.6867
  contributor:
    fullname: S Yu
– volume: 19
  start-page: 1244
  year: 2020
  ident: 43914_CR41
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-020-0680-1
  contributor:
    fullname: H Wang
– volume: 11
  start-page: 1
  year: 2020
  ident: 43914_CR51
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-15569-2
  contributor:
    fullname: B Zuo
– volume: 55
  start-page: 5452
  year: 2016
  ident: 43914_CR17
  publication-title: Angew Chem. Int. Ed.
  doi: 10.1002/anie.201509601
  contributor:
    fullname: H Wang
– volume: 7
  year: 2017
  ident: 43914_CR26
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-01731-2
  contributor:
    fullname: A Morales-Kastresana
– volume: 415
  start-page: 230
  year: 2006
  ident: 43914_CR43
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(06)15015-6
  contributor:
    fullname: ST Laughlin
– volume: 14
  start-page: e1824
  year: 2022
  ident: 43914_CR49
  publication-title: WIREs Nanomed. Nanobiotechnol.
  doi: 10.1002/wnan.1824
  contributor:
    fullname: Y Bo
– volume: 411
  start-page: 182
  year: 2017
  ident: 43914_CR35
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.09.022
  contributor:
    fullname: H Liu
– volume: 13
  start-page: 415
  year: 2017
  ident: 43914_CR16
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2297
  contributor:
    fullname: H Wang
– ident: 43914_CR54
  doi: 10.3791/2259
– volume: 16
  start-page: 782
  year: 2008
  ident: 43914_CR30
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2008.1
  contributor:
    fullname: S Dai
– volume: 155
  start-page: 113690
  year: 2022
  ident: 43914_CR13
  publication-title: Biomed. Pharmther.
  doi: 10.1016/j.biopha.2022.113690
  contributor:
    fullname: NF Hosseini
– volume: 330
  start-page: 101
  year: 2021
  ident: 43914_CR10
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2020.12.017
  contributor:
    fullname: M Severic
– volume: 20
  start-page: 321
  year: 2020
  ident: 43914_CR40
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-019-0269-6
  contributor:
    fullname: DJ Irvine
– volume: 303
  start-page: 1526
  year: 2004
  ident: 43914_CR37
  publication-title: Science
  doi: 10.1126/science.1093620
  contributor:
    fullname: F Heil
– volume: 275
  start-page: 120964
  year: 2021
  ident: 43914_CR9
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.120964
  contributor:
    fullname: L Cheng
– volume: 10
  start-page: 499
  year: 2011
  ident: 43914_CR47
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/erv.10.174
  contributor:
    fullname: C Bode
– volume: 75
  start-page: 3317
  year: 1978
  ident: 43914_CR5
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.75.7.3317
  contributor:
    fullname: H Haigler
– volume: 28
  start-page: 129
  year: 2020
  ident: 43914_CR8
  publication-title: J. Drug Target.
  doi: 10.1080/1061186X.2019.1641508
  contributor:
    fullname: Y Lin
– volume: 23
  start-page: 1541
  year: 2009
  ident: 43914_CR28
  publication-title: FASEB J.
  doi: 10.1096/fj.08-122184
  contributor:
    fullname: MW Graner
– volume: 20
  start-page: 1
  year: 2022
  ident: 43914_CR32
  publication-title: Cell Commun. Signal.
  doi: 10.1186/s12964-022-00959-4
  contributor:
    fullname: J Rezaie
– volume: 363
  start-page: 411
  year: 2010
  ident: 43914_CR46
  publication-title: N Engl. J. Med.
  doi: 10.1056/NEJMoa1001294
  contributor:
    fullname: PW Kantoff
– volume: 14
  start-page: 447
  year: 2015
  ident: 43914_CR48
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2015.966085
  contributor:
    fullname: KA Martins
SSID ssj0000391844
Score 2.5439265
Snippet As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However,...
Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications....
Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications....
SourceID doaj
proquest
crossref
pubmed
springer
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 8047
SubjectTerms 13/31
14/1
14/19
14/34
631/250/251/1567
631/61/350/354
631/67/1059/2325
631/67/1059/4042
639/166/985
Antitumor activity
Cancer
Cancer vaccines
Cancer Vaccines - metabolism
CD8 antigen
Cell activation
Cell Communication
Cell interactions
Cellular communication
Chemical synthesis
Conjugation
Dendritic cells
Extracellular vesicles
Extracellular Vesicles - metabolism
Humanities and Social Sciences
Humans
Lymphocytes
Lymphocytes T
Lymphoma
Melanoma
Metabolism
multidisciplinary
Science
Science (multidisciplinary)
Skin Neoplasms - metabolism
Survival
Tags
Therapeutic applications
Toll-like receptors
Tumors
Vaccines
Vesicles
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1NSx0xMIhQ8CK1fnTVlhS86WL25fvYlspDeD0peAv5WhXKvvJ2Ffz3TpJ9T0Wll16zsyGZmcxHMh8IHU2ETXeNkzroJtYs8Fg76wic-AkoCw2jPOUOz36L6SU7v-JXz1p9pZiwUh64IO608ZqEVlMvmsg8s6rlXAbtuVe25bqk7hH9zJnKMphqcF3YmCVDqDrtWZYJoKLqlGzKavVCE-WC_W9Zma9eSLPiOfuINkeLEX8vK91Ca7H7hD6UHpIP26ifxQEI-efW48Gm6-NrPG8xiNyFTZfyKcoU38c-R79h2wUcnsKEMmR3k4MA3v4FJy0XsE8gMGh9eofvd9Dl2a-Ln9N67KRQe6b4UFvpmBaMu8g9F1aBUvbCuVYSGSXlTHiwHGQrAKWagrusW2VpBEoxSlxDA91F6928i58RdsSplFeirRQsCKFkIJa4VoCsCN6HCh0vsWr-loIZJj90U2UKDQzQwGQaGFWhHwnxK8hU7DoPAAuYkQXMv1igQodLspnxBPYGHEnVCDAHSYW-rT7D2UmItF2c3xUYzcGhlRXaK-RerYSmXg9KwOQnS_o_Tf7-hvb_x4YO0Ebqap-jZvghWh8Wd_EL2D6D-5rZ_BEmYf80
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Li9UwFA46IrgR31ZHieBOw6Q375WoeB2EceXA7EJeHQVpx9uO4L_3nLT3XsTRbZqW03w575McQl6udMBY44pl1xYmsyoshsiB41egLByMKjw7fPJZH5_KT2fqbAm4jUtZ5VYmVkGdh4Qx8iNwDGyrQb3zNxc_GHaNwuzq0kLjOrnRroxB58uuP-5iLHj7uZVyOSvDhT0aZZUMoKgYHjmVzP6hj-q1_VfZmn_lSav6Wd8htxe7kb6dgb5LrpX-Hrk5d5L8dZ-MJ2UCOL9_S3QKGEQ-p0NHQfBuAobmsdaU_ixjrYGjoc8074uF6sz-ay0FuPoVirou04RTYDAkzMaPD8jp-sOX98ds6afAkrRqYsFE6bRUsaikdLCgmpOOsTPcFCOU1AnsB9NpGzonwGl2nQ2iAF5S8NiKLB6Sg37oy2NCI48WT5e4YLTMWluTeeCx0yAxckq5Ia-2q-ov5mszfE13C-tnDDxg4CsG3jbkHS78biZeeV0Hhs25XzjIt8nxDIQl3RaZZLCdUia7pBLQq5xryOEWNr_w4ej3u6YhL3aPgYNwIUNfhst5jlPg1pqGPJrh3lEisOOD1fDx11v89x__9w89-T8tT8kt7Fpfq2LUITmYNpflGdg2U3xeN_BvIWD2Dw
  priority: 102
  providerName: ProQuest
– databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Na9VAEB-0IngpfjdaywreNDR5-33UR0sp1JOF3pb9ShUkrzSp4H_fmU3eK8XnodfN7LLZXyYzO58AnxbKk61xUSfb5lokmevgQ4Mcv0BhYXFUUu7w2Xd1ci5OL-TFXCaHcmHu-e-5ORxEYWWULDXliIraPIYnKIMNhW8t1XJjT6FK50aIOS9m-9R7sqeU6N-mV_7jEy2i5vg57M46Ivs6gfoCHuX-JTydukb-fQXDWR4Rut-_Ihs9GYwv2apj-JO99mSGp7hS9icPJd6N-T6xdBcYVCj7n8Xtv30KI7mWWCQSHPSRPO_Dazg_PvqxPKnn3gl1FEaOtddBWCVkyDJK5Q2K4ahC6HSjs-ZSqIi6gu6U8Z3leEG2nfE8IzaCN6Hlib-BnX7V5z1goQmGMkms10okpYxOjW9Cp_DvkGJMFXxen6q7mkpkuOLa5sZNGDjEwBUMnKngGx38hpLKW5cBRN3N3OLaaJuEG4uqzSIKbzopdbJRRtyvtLaC_TVsbua5weHV0bQKFcCmgo-bx8gtdJC-z6ubicZKvMLqCt5OcG92wqm7g1G4-Jc1_neL__-F3j2M_D08o471JSJG7sPOeH2TP6BeM4aD8kHfArpT7vo
  priority: 102
  providerName: Springer Nature
Title Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines
URI https://link.springer.com/article/10.1038/s41467-023-43914-8
https://www.ncbi.nlm.nih.gov/pubmed/38052869
https://www.proquest.com/docview/2898165140
https://search.proquest.com/docview/2898957177
https://doaj.org/article/1c90df93c61e4c4a8f557d9c5c8af599
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR1pa9RA9NEDpV_E22hdIvhNo8lmzg8i26VrWWgRdWG_DXOlCiXbblKx_943k2QruP2SwBxh8t68ece8A-DtmOlgaxxnThY-I476zGiTI8WPkVlIbKUhdvj0jJ0syHxJlzswlDvqAdhsVe1CPanF-uLDn6ubz0jwn7qQcfGxIZHckftkIY6UZGIX9scENfXgyteL-_Fkxl5BSB87s33qAdwvQ5p_EVyg_2FVMaP_NjH0vyvUyJlmD-FBL1Kmk24PPIIdXz-Ge12RyZsn0Jz6FjF98cumrQ725fN0VaV4Jq91sNoHN9T0t2-ie1yqa5e6Wz-iOLL-Gb0Etk9JAxt0qQ1DsFHbcFHfPIXF7PjH9CTrSy1klgjaZpobIhmhxlNLmRbItS0zpuI597ykhFkULXjFhK5kifq0rIQuPaKSlLkpSlc-g716VfsXkJrciBB4IjVnxDEmuMt1biqGh4mz1iXwboCquuwyaqh4E14K1aFDITpURIcSCRwFwG9GhmzYsWG1Plc9canCytzhwiwrPLFEi4pS7qSlFtdLpUzgcECbGnaYQk1TFAzlxTyBN5tuJK4ASF371XU3RlLUeHkCzzt0b1Yy7JIE3g_4v_343T_08s4PvYKDUMs--srQQ9hr19f-NUo8rRnBLl9yfIrZlxHsTybz73N8Hx2fff2GrVM2HUVbwihu97-d-__i
link.rule.ids 315,783,787,867,2109,12068,12777,21400,24330,27936,27937,31731,31732,33385,33386,33756,33757,41132,42201,43322,43612,43817,51588,74073,74363,74630
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEF8Sa0gJG4QVRn_Yh9qgCxLNDtqZV6s_xKqVQlZZMi8e-ZcbK7QhSuziSa-PM8PJ7xEPJmphzGGmdlNFUqRZSp9M4zkPgZGAsDoxJrh5dHanEivp7K0yng1k9plWudmBV17ALGyPdhY6ArBeadHVz-KLFrFJ6uTi00bpJbgoOtxkrx-edNjAVvP9dCTLUyjOv9XmTNAIaqxJJTUeo_7FG-tv86X_Ovc9Jsfub3yb3Jb6TvR6AfkBupfUhuj50kfz0i_TINAOfFeaCDwyDyGe0aCop35TA0j7mm9Gfqcw4cdW2kcZsslCnb7zkV4PpXKNq6SAOSwKALeBrfPyYn80_HHxfl1E-hDELLoXS1F0YJ6ZMMUjkNpjko75ua1anmUqgA_kPdKO0aw2HTbBrteAK8BGe-4pE_ITtt16ZnhHrmNVaXGFcrEZXSdWSO-UaBxoghxIK8Xc-qvRyvzbD5uJtrO2JgAQObMbC6IB9w4jeUeOV1HuhWZ3aSIFsFwyIwFlSVRBBON1LW0QQZgF9pTEH21rDZSQ57u101BXm9eQwShBPp2tRdjTRGwra2LsjTEe4NJxw7PmgFH3-3xn_78X__0PP_8_KK3FkcLw_t4Zejb7vkLnawzxkyco_sDKur9AL8nMG_zIv5N7YS-PE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA66RemLeO9q1Qi-6bCZzf1JrHaply5FLPQt5DZVkJm6MxX8955ksruI1ddMJiT5kpzknO-cg9CLubBJ1zivgq5jxQKPlbOOwI6fg7DQUMqT7_DxUhydsg9n_Kzwn_pCq1yfifmgDp1POvIZPAxULUC8k1lTaBEn7xavL35UKYNUsrSWdBrX0Y5kgpIJ2jk4XJ583mhcUix0xVjxnCFUzXqWzwkQW1VyQGWV-kM65SD-V908_7KaZmG0uI1ulVskfjPCfgddi-1ddGPMK_nrHuqP4wDgfv_m8WCTSvkcdw2GsaxsUtQn5in-GfvMiMO2DThsqUO5Zvs1EwOu_gUnyRewT1Wg0Ppkm-_vo9PF4Ze3R1XJrlB5pvhQWemYFoy7yD0XVoGg9sK5RhIZJeVMeLhNyEYo22gKT2jdKEsjoMcocTUN9AGatF0b9xB2xKnka6KtFCwIoWQglrhGwPkRvA9T9HI9q-ZiDKJhsvGbKjNiYAADkzEwaooO0sRvaqYA2LmgW52bsp9M7TUJ0DEv6sg8s6rhXAbtuYf-cq2naH8Nmym7sjfbNTRFzzefYT-libRt7C7HOprDI1dO0cMR7k1PaMr_oAQ0_mqN_7bxfw_o0f_78gzdhJVsPr1ffnyMdlM6-0yX4ftoMqwu4xO49AzuaVnNvwG--v6O
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+tagging+of+extracellular+vesicles+and+development+of+enhanced+extracellular+vesicle+based+cancer+vaccines&rft.jtitle=Nature+communications&rft.au=Bhatta%2C+Rimsha&rft.au=Han%2C+Joonsu&rft.au=Liu%2C+Yusheng&rft.au=Bo%2C+Yang&rft.date=2023-12-05&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=8047&rft_id=info:doi/10.1038%2Fs41467-023-43914-8&rft_id=info%3Apmid%2F38052869&rft.externalDocID=38052869
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon